PubMed · 2001 · 49 citations · 24 references
Open access
MedicineOncologyPathologyCellular MetabolismDiagnostic RadiologySpectroscopic AnalysisMagnetic Resonance ImagingMagnetic Resonance SpectroscopySquamous Cell CarcinomaTumor CharacterizationTumor DetectionTumor ImagingBenign DiagnosisCholine ImagingCholine MetabolismGlomus TumorMagnetic Resonance Spectroscopic ImagingMetabolic Tumor CharacterizationMetabolic Tumor Imaging
BACKGROUND AND PURPOSE: The choline (Cho)/creatine (Cr) ratio has been shown to be a reliable proton MR spectroscopy metabolic marker for differentiating squamous cell carcinoma (SCCA) from normal muscle in the upper aerodigestive tract. However, it is unclear whether the Cho/Cr ratio can be used to differentiate a malignant tumor from a benign neoplasm in the extracranial head and neck. Our purpose was to determine whether the Cho/Cr ratio can be used to differentiate benign from malignant tumors in this region. METHODS: In vitro one-dimensional proton MR spectroscopy (2,000/136,272 [TR/TE]) was performed at 11 T on tissue specimens obtained from glomus tumors (n = 3), inverting papilloma (n = 1), and schwannoma (n = 1). Cho/Cr area ratios were calculated and compared with similar, previously reported in vitro (11 T) findings and with samples of SCCA and normal muscle. RESULTS: The Cho/Cr ratio was elevated in relation to muscle in all benign tumors at TE = 136 (glomus tumors = 4.52, inverting papilloma = 3.85, schwannoma = 2.2) and at TE = 272 (glomus tumors = 8.01, inverting papilloma = 2.1, schwannoma = 4.28). The average Cho/Cr ratio for benign lesions was 3.92 (TE = 136) and 6.11 (TE = 272). The Cho/Cr ratio was significantly higher in benign tumors than in both SCCA and muscle. The average Cho/Cr ratio for muscle at TEs of 136 and 272 was 1.16 and 1.31, respectively, whereas for SCCA the average Cho/Cr ratio at TEs of 136 and 272 was 1.67 and 2.45, respectively. CONCLUSION: In our small group, the Cho/Cr ratio was significantly higher in benign tumors than in muscle and SCCA of the extracranial head and neck.
24
Eugene Friedman, Craig D. Friedman · International Journal of Oral Surgery · 1978 · 672 citations
Medicine, Neck Surgery, Oncology +10
Proton MR Spectroscopy of Intracranial Tumours
Steven S. Gill, D. G. T. Thomas, Nicholas van Bruggen et al. · Journal of Computer Assisted Tomography · 1990 · 306 citations
Medicine, Biochemistry, Oncology +17
Tumors of the Peripheral Nerves
Charles F. Geschickter · The American Journal of Cancer · 1935 · 179 citations
Medicine, Anatomy, Neuroscience +16